114 related articles for article (PubMed ID: 2978064)
1. Episodic barrel rotations induced by intrastriatal injection of quinolinic acid in rats. Inhibition by anticonvulsants.
Marrannes R; Wauquier A
Pharmacol Biochem Behav; 1988 Sep; 31(1):153-62. PubMed ID: 2978064
[TBL] [Abstract][Full Text] [Related]
2. Anticonvulsant drugs effective against human temporal lobe epilepsy prevent seizures but not neurotoxicity induced in rats by quinolinic acid: electroencephalographic, behavioral and histological assessments.
Vezzani A; Wu HQ; Tullii M; Samanin R
J Pharmacol Exp Ther; 1986 Oct; 239(1):256-63. PubMed ID: 2945004
[TBL] [Abstract][Full Text] [Related]
3. Antagonism of seizures induced by the administration of the endogenous convulsant quinolinic acid into rat brain ventricles.
Lapin IP; Prakhie IB; Kiseleva IP
J Neural Transm; 1986; 65(3-4):177-85. PubMed ID: 2940335
[TBL] [Abstract][Full Text] [Related]
4. Studies on the disposition of quinolinic acid after intracerebral or systemic administration in the rat.
Foster AC; Miller LP; Oldendorf WH; Schwarcz R
Exp Neurol; 1984 May; 84(2):428-40. PubMed ID: 6232146
[TBL] [Abstract][Full Text] [Related]
5. [Effects of antagonists of exciting amino acids on the neuro-destructive effect of quinolinic acid in vitro in comparison with their anticonvulsive action in situ].
Khaspekov LG; Lapin IP; Ryzhov IV; Viktorov IV
Biull Eksp Biol Med; 1989 Aug; 108(8):190-3. PubMed ID: 2529920
[TBL] [Abstract][Full Text] [Related]
6. Short- and long-term consequences of intracranial injections of the excitotoxin, quinolinic acid, as evidenced by GFA immunohistochemistry of astrocytes.
Björklund H; Olson L; Dahl D; Schwarcz R
Brain Res; 1986 Apr; 371(2):267-77. PubMed ID: 2938667
[TBL] [Abstract][Full Text] [Related]
7. [Synergism of picrotoxin with the endogenous convulsants kynurenine and quinolinic acid and its antagonism with their antagonists].
Lapin IP; Ryzhov IV
Farmakol Toksikol; 1985; 48(6):13-7. PubMed ID: 3002845
[TBL] [Abstract][Full Text] [Related]
8. Intracerebral quinolinic acid injection in the rat: effects on dopaminergic neurons.
Mazzari S; Aldinio C; Beccaro M; Toffano G; Schwarcz R
Brain Res; 1986 Aug; 380(2):309-16. PubMed ID: 2944562
[TBL] [Abstract][Full Text] [Related]
9. Quinolinic acid-induced seizures, but not nerve cell death, are associated with extracellular Ca2+ decrease assessed in the hippocampus by brain dialysis.
Vezzani A; Wu HQ; Angelico P; Stasi MA; Samanin R
Brain Res; 1988 Jun; 454(1-2):289-97. PubMed ID: 2970276
[TBL] [Abstract][Full Text] [Related]
10. On the excitotoxic properties of quinolinic acid, 2,3-piperidine dicarboxylic acids and structurally related compounds.
Foster AC; Collins JF; Schwarcz R
Neuropharmacology; 1983 Dec; 22(12A):1331-42. PubMed ID: 6229703
[TBL] [Abstract][Full Text] [Related]
11. Quinolinic acid elevates striatal and pallidal Met-enkephalin levels: the role of enkephalin synthesis and release.
Ruzicka BB; Day R; Jhamandas K
Brain Res; 1991 Oct; 562(1):117-25. PubMed ID: 1839239
[TBL] [Abstract][Full Text] [Related]
12. Effect of quinolinic acid in the nucleus basalis magnocellularis on cortical high-affinity choline uptake.
Metcalf RH; Boegman RJ; Quirion R; Riopelle RJ; Ludwin SK
J Neurochem; 1987 Aug; 49(2):639-44. PubMed ID: 2955081
[TBL] [Abstract][Full Text] [Related]
13. Quinolinic acid does not spare striatal neuropeptide Y-immunoreactive neurons.
Boegman RJ; Smith Y; Parent A
Brain Res; 1987 Jul; 415(1):178-82. PubMed ID: 2957024
[TBL] [Abstract][Full Text] [Related]
14. Quinolinic acid lesions of rat striatum abolish D1- and D2-dopamine receptor-mediated catalepsy.
Calderon SF; Sanberg PR; Norman AB
Brain Res; 1988 May; 450(1-2):403-7. PubMed ID: 2969764
[TBL] [Abstract][Full Text] [Related]
15. Effect of intrahippocampal quinolinic acid infusion on the amygdala kindling in rat.
Ping HX; Liu GQ; Xie L; Wu HQ
Zhongguo Yao Li Xue Bao; 1991 Jul; 12(4):304-7. PubMed ID: 1807077
[TBL] [Abstract][Full Text] [Related]
16. Dextromethorphan does not protect against quinolinic acid neurotoxicity in rat striatum.
Engber TM; Chase TN
Neurosci Lett; 1988 Dec; 95(1-3):269-74. PubMed ID: 2976130
[TBL] [Abstract][Full Text] [Related]
17. Systemic treatments with GM1 ganglioside reduce quinolinic acid-induced striatal lesions in the rat.
Lombardi G; Zanoni R; Moroni F
Eur J Pharmacol; 1989 Dec; 174(1):123-5. PubMed ID: 2612575
[TBL] [Abstract][Full Text] [Related]
18. Protective effects of the antioxidant selenium on quinolinic acid-induced neurotoxicity in rats: in vitro and in vivo studies.
Santamaría A; Salvatierra-Sánchez R; Vázquez-Román B; Santiago-López D; Villeda-Hernández J; Galván-Arzate S; Jiménez-Capdeville ME; Ali SF
J Neurochem; 2003 Jul; 86(2):479-88. PubMed ID: 12871589
[TBL] [Abstract][Full Text] [Related]
19. Effects of intracerebral injections of quinolinic acid on serotonergic neurons in the rat brain.
Aldinio C; Mazzari S; Toffano G; Köhler C; Schwarcz R
Brain Res; 1985 Aug; 341(1):57-65. PubMed ID: 2412634
[TBL] [Abstract][Full Text] [Related]
20. Quinolinic acid evokes [3H]acetylcholine release in striatal slices: mediation by NMDA-type excitatory amino acid receptors.
Lehmann J; Schaefer P; Ferkany JW; Coyle JT
Eur J Pharmacol; 1983 Dec; 96(1-2):111-5. PubMed ID: 6141057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]